Gene expression profiling of epithelial-mesenchymal transition in primary breast cancer cell culture

Anticancer Research

Volumn 34, Issue 5, 2014, Pages 2173-2184

  Minafra, Luigi ^a   Bravata, Valentina ^a   Forte, Giusi Irma ^a   Cammarata, Francesco Paolo ^a   Gilardi, Maria Carla ^a,b,c   Messa, Cristina ^a,b,d  

^a CNR   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

^d SAN GERARDO HOSPITAL   (Italy)

Author keywords

Breast cancer; CDNA microarray; EMT; Epithelial mesenchymal transition; Primary cell culture

Indexed keywords

ACTIN; AMPHIREGULIN; CADHERIN; CATHEPSIN K; COLLAGEN TYPE 6; COLLAGEN TYPE 8; CONNECTIVE TISSUE GROWTH FACTOR; CYTOKERATIN 19; CYTOKERATIN 5; CYTOKERATIN 8; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; FIBULIN; FOLLISTATIN; INHIBITOR OF DIFFERENTIATION 2; INTERLEUKIN 6; LATENT TRANSFORMING GROWTH FACTOR BETA BINDING PROTEIN; NERVE CELL ADHESION MOLECULE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; SEPRASE; STROMELYSIN; THROMBOSPONDIN 1; TISSUE FACTOR PATHWAY INHIBITOR; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR TWIST; TRANSFORMING GROWTH FACTOR BETA1; UVOMORULIN; VIMENTIN; TRANSCRIPTOME;

ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; BREAST CANCER; CANCER CELL CULTURE; CELL ISOLATION; CELL MIGRATION; CELL MOTILITY; COMPARATIVE STUDY; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE INTERACTION; GENE ONTOLOGY; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MICROARRAY ANALYSIS; PRIMARY CELL; PRIMARY CULTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; BREAST TUMOR; CDNA MICROARRAY; CELL CULTURE; CELL MOTION; DNA MICROARRAY; EMT; FEMALE; GENETICS; PAGET NIPPLE DISEASE; PRIMARY CELL CULTURE; REAL TIME POLYMERASE CHAIN REACTION;

BREAST CANCER; CDNA MICROARRAY; EMT; EPITHELIAL-MESENCHYMAL TRANSITION; PRIMARY CELL CULTURE;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL MOVEMENT; CELLS, CULTURED; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTOME;

EID: 84902989161     PISSN: 02507005     EISSN: 17917530     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO and Kennecke H: Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 28: 1684-1691, 2010.
2. Harbeck N, Sotlar K, Wuerstlein R and Doisneau-Sixou S: Molecular and protein markers for clinical decision making in breast cancer: Today and tomorrow. Cancer Treat Rev 40(3): 434-44, 2014.
3. Bravatà V, Cammarata FP, Forte GI and Minafra L: "Omics" of HER2-positive breast cancer. OMICS 17(3): 119-129, 2013.
4. 18FDG uptake in breast cancer patients: a preliminary research. J Exp Clin Cancer Res 32: 23, 2013.
5. Sotiriou C and Pusztai L: Gene-expression signatures in breast cancer. N Engl J Med 60: 790-800, 2009.
6. Sotiriou C and Piccart MJ: Taking gene-expression profiling to the clinic: When will molecular signatures become relevant to patient care? Nat Rev Cancer 7: 545-553, 2007.
7. Reis-Filho JS, Westbury C and Pierga JY: The impact of expression profiling on prognostic and predictive testing in breast cancer. J Clin Pathol 59: 225-231, 2006.
8. Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, Desmedt C, Ignatiadis M, Sengstag T, Schütz F, Goldstein DR, Piccart M and Delorenzi M: Meta-Analysis of gene expression profiles in breast cancer: Toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res 10: R65, 2008.
9. Weigelt B, Baehner FL and Reis-Filho JS: The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. J Pathol 220: 263-280, 2010.
10. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu J, Jatkoe T, Berns EM, Atkins D and Foekens JA: Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671-679, 2005.
11. Smid M, Wang Y, Klijn JG, Sieuwerts AM, Zhang Y, Atkins D, Martens JW and Foekens JA: Genes associated with breast cancer metastatic to bone. J Clin Oncol 24: 2261-2267, 2006.
12. Smid M, Wang Y, Zhang Y, Sieuwerts AM, Yu J, Klijn JG, Foekens JA and Martens JW: Subtypes of breast cancer show preferential site of relapse. Cancer Res 68: 3108-3114, 2008.
13. Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO and Gelmon K: Metastatic behavior of breast cancer subtypes. J Clin Oncol 28: 3271-3277, 2010.
14. Baum B, Settleman J and Quinlan MP: Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 19: 294-308, 2008.
15. Hugo H, Ackland ML, Blick T, Lawrence MG, Clements JA, Williams ED and Thompson EW: Epithelial-Mesenchymal and Mesenchymal-Epithelial Transitions in Carcinoma Progression. J Cell Physiol 213: 374-383, 2007.
16. Yang J and Weinberg RA: Epithelial-mesenchymal transition: at the crossroads of development and tumour metastasis. Dev Cell 14: 818-829, 2008.
17. Tanos B and Rodriguez-Boulan E: The epithelial polarity program: machineries involved and their hijacking by cancer. Oncogene 27(55): 6939-6957, 2008.
18. Tomaskovic-Crook E, Thompson EW and Thiery JP: Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res 11(6): 213, 2009.
19. Minafra L, Norata R, Bravatà V, Viola M, Lupo C, Gelfi C, Messa C: Unmasking epithelial-mesenchymal transition in a breast cancer primary culture: A study report. BMC Res Notes 5: 343, 2012.
20. Wendt MK, Jason A, Smith BS and Schiemann WP: Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression. Oncogene 29: 6485-6498, 2010.
21. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J and Weinberg RA: The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 133(4): 704-715, 2008.
22. Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J, Hartwell K, Onder TT, Gupta PB, Evans KW, Hollier BG, Ram PT, Lander ES, Rosen JM, Weinberg RA and Mani SA: Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA 107(35): 15449-15454, 2010.
23. Sims, AH, Larionov AA, Harrison DJ and Katz E: Use of microarray analysis to investigate EMT gene signatures. Methods Mol Biol 1046: 85-95, 2013.
24. Nishikata T, Ishikawa M, Matsuyama T, Takamatsu K, Fukuhara T and Konishi Y: Primary culture of BC: a model system for epithelial-mesenchymal transition and cancer stem cells. Anticancer Res 33(7): 2867-2873, 2013.
25. Edgar R, Domrachev M and Lash AE: Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30(1): 207-210, 2002.
26. Rozen S and Skaletsky HJ: Primer3 on the WWW for general users and for biologist programmers. In: Bioinformatics Methods and Protocols: Methods in Molecular Biology. Krawetz S and Misener S (eds.). Humana Press, Totowa, NJ, pp. 365-386, 2000.
27. Primer3 tool. http//fokker.wi.mit.edu/primer3.
28. Becker KG, Hosack DA, Dennis G Jr., Lempicki RA, Bright TJ, Cheadle C and Engel J: PubMatrix: a tool for multiplex literature mining. BMC Bioinformatics 10: 4: 61, 2003.
29. Gröger CJ, Grubinger M, Waldhör T, Vierlinger K and Mikulits W: Meta-Analysis of gene expression signatures defining the epithelial to mesenchymal transition during cancer progression. PLoS One 7(12): e51136, 2012.
30. Zientek-Targosz H1, Kunnev D, Hawthorn L, Venkov M, Matsui S, Cheney RT and Ionov Y: Transformation of MCF-10A cells by random mutagenesis with frameshift mutagen ICR191: A model for identifying candidate breast-tumour suppressors. Molecular Cancer 7: 51, 2008.
31. Zhang Q, Fan H, Shen J, Hoffman RM, Xing HR: Human breast cancer cell lines co-express neuronal, epithelial, and melanocytic differentiation markers in vitro and in vivo. PLoS One 5: e9712, 2010.
32. Moustakas A and Heldin CH: Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98: 1512-1520, 2007.
33. Wendt MK, Allington TM and Schiemann WP: Mechanisms of the epithelial-mesenchymal transition by TGF-beta. Future Oncol 5: 1145-1168, 2009.
34. Szklarczyk D, Franceschini A, Kuhn M, Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork P, Jensen LJ and von Mering C: The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 39: D561-568, 2011.
35. Lobert S, Graichen ME and Morris K: Coordinated regulation of β-tubulin isotypes and epithelial-to-mesenchymal transition protein ZEB1 in BC cells. Biochemistry 52(32): 5482-90, 2013.
36. Bundy LM and Sealy L: CCAAT/enhancer binding protein beta (C/EBPbeta)-2 transforms normal mammary epithelial cells and induces epithelial to mesenchymal transition in culture. Oncogene 22(6): 869-83, 2003.
37. Park J and Scherer PE: Adipocyte-derived endotrophin promotes malignant tumour progression. J Clin Invest 22: 4243-4256, 2012.
38. Park J and Scherer PE: Endotrophin a novel factor linking obesity with aggressive tumour growth. Oncotarget 2: 1487-1488, 2012.
39. Park J, Morley TS and Scherer PE: Inhibition of endotrophin, a cleavage prouct of collagen VI, confers cisplatin sensitivity to tumours. EMBO Mol Med 5(6): 935-948, 2013.
40. Stoll SW, Rittié L, Johnson JL and Elder JT: Heparin-binding EGF-like growth factor promotes epithelial-mesenchymal transition in human keratinocytes. J Invest Dermatol 132(9): 2148-2157, 2012.
41. Yang N, Morrison CD, Liu P, Miecznikowski J, Bshara W, Han S, Zhu Q, Omilian AR, Li X and Zhang J: TAZ induces growth factor-independent proliferation through activation of EGFR ligand amphiregulin. Cell Cycle 11(15): 2922-2930, 2012.
42. Huang Y, Fernandez SV, Goodwin S, Russo PA, Russo IH, Sutter TR and Russo J: Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Cancer Res 67: 11147-11157, 2007.
43. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES and Weinberg RA: Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: 3645-3654, 2008.
44. Thomson S, Petti F, Sujka-Kwok I, Mercado P, Bean J, Monaghan M, Seymour SL, Argast GM, Epstein DM and Haley JD: A systems view of epithelial-mesenchymal transition signaling states. Clin Exp Metastasis 28: 137-155, 2011.
45. Horiguchi K, Sakamoto K, Koinuma D, Semba K, Inoue A, Inoue S, Fujii H, Yamaguchi A, Miyazawa K, Miyazono K and Saitoh M: TGF-β drives epithelial-mesenchymal transition through δEF1-mediated down-regulation of ESRP. Oncogene 31(26): 3190-3201, 2012.
46. Shapiro IM, Cheng AW, Flytzanis NC, Balsamo M, Condeelis JS, Oktay MH, Burge CB and Gertler FB: An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet 7: e1002218, 2011.
47. Warzecha CC and Carstens RP: Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT). Semin Cancer Biol 2(5-6): 417-27, 2012.
48. Horvath A, Pakala SB, Mudvari P, Reddy SD, Ohshiro K, Casimiro S, Pires R, Fuqua SA, Toi M, Costa L, Nair SS, Sukumar S and Kumar R: Novel insights into BC genetic variance through RNA sequencing. Sci Rep 3: 2256, 2013.
49. Ostman A and Augsten M: Cancer-Associated fibroblasts and tumour growth-bystanders turning into key players. Curr Opin Genet Dev 19: 67-73, 2009.
50. Schulte J, Weidig M, Balzer P, Richter P, Franz M, Junker K, Gajda M, Friedrich K, Wunderlich H, Östman A, Petersen I and Berndt A: Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells. Histochem Cell Biol 138(6): 847-60, 2012.
51. Mefford D and Mefford J: Stromal genes add prognostic information to proliferation and histoclinical markers: a basis for the next generation of BC gene signatures. PLoS One 7(6): e37646, 2012.
52. Xiong D, Li G, Li K, Xu Q, Pan Z, Ding F, Vedell P, Liu P, Cui P, Hua X, Jiang H, Yin Y, Zhu Z, Li X, Zhang B, Ma D, Wang Y and You M: Exome sequencing identifies MXRA5 as a novel cancer gene frequently mutated in non-small cell lung carcinoma from Chinese patients. Carcinogenesis 33(9): 1797-1805, 2012.
53. Minafra L, Bravatà V, Russo G, Ripamonti M and Gilardi MC: Gene expression profiles in irradiated cancer cells. AIP Conf. Proc. 2013, 1546: 93. doi: 10.1063/1.4816614
54. Chen W, Wu S, Zhang G, Wang W and Shi Y: Effect of AKT inhibition on epithelial-mesenchymal transition and ZEB1-potentiated radiotherapy in nasopharyngeal carcinoma. Oncol Lett 6(5): 1234-1240, 2013.